Literature DB >> 15070727

Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum.

Puran S Sijwali1, Philip J Rosenthal.   

Abstract

Erythrocytic malaria parasites degrade hemoglobin in an acidic food vacuole to acquire free amino acids and maintain parasite homeostasis. Hemoglobin hydrolysis appears to be a cooperative process requiring cysteine proteases (falcipains) and aspartic proteases (plasmepsins), but the specific roles of different enzymes in this process are unknown. We previously showed that falcipain-2 is a major trophozoite food vacuole cysteine protease. To characterize the specific role of falcipain-2, we disrupted the falcipain-2 gene and assessed the effect of this alteration. Falcipain-2-knockout trophozoites had markedly diminished cysteine protease activity and swollen, dark staining food vacuoles, consistent with a block in hemoglobin hydrolysis, as caused by cysteine protease inhibitors. However, more mature stages of knockout parasites were indistinguishable from wild-type parasites and developed normally. The knockout parasites had decreased and delayed expression of falcipain-2, which appeared to be directed by increased transcription of a second copy of the gene (falcipain-2'). Expression of other falcipains and plasmepsins was similar in wild-type and knockout parasites. Compared with wild-type, knockout parasites were about 3 times more sensitive to the cysteine protease inhibitors E-64 and leupeptin, and over 50-fold more sensitive to the aspartic protease inhibitor pepstatin. Our results assign a specific function for falcipain-2, the hydrolysis of hemoglobin in trophozoites. In addition, they highlight the cooperative action of cysteine and aspartic proteases in hemoglobin degradation by malaria parasites.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070727      PMCID: PMC384756          DOI: 10.1073/pnas.0307720101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.

Authors:  A Singh; P J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 2.  Proteases of protozoan parasites.

Authors:  P J Rosenthal
Journal:  Adv Parasitol       Date:  1999       Impact factor: 3.870

Review 3.  Biological roles of proteases in parasitic protozoa.

Authors:  Michael Klemba; Daniel E Goldberg
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

4.  Stage-specific antimalarial activity of cysteine protease inhibitors.

Authors:  Bhaskar R Shenai; Andrey V Semenov; Philip J Rosenthal
Journal:  Biol Chem       Date:  2002-05       Impact factor: 3.915

5.  Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3.

Authors:  P S Sijwali; B R Shenai; J Gut; A Singh; P J Rosenthal
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

6.  Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum.

Authors:  K K Eggleson; K L Duffin; D E Goldberg
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

Review 7.  Proteases involved in erythrocyte invasion by the malaria parasite: function and potential as chemotherapeutic targets.

Authors:  M J Blackman
Journal:  Curr Drug Targets       Date:  2000-07       Impact factor: 3.465

8.  Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine.

Authors:  Ritu Banerjee; Jun Liu; Wandy Beatty; Lorraine Pelosof; Michael Klemba; Daniel E Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

Review 9.  Cysteine proteases of malaria parasites: targets for chemotherapy.

Authors:  Philip J Rosenthal; Puran S Sijwali; Ajay Singh; Bhaskar R Shenai
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

10.  Transcriptional analysis of genes encoding enzymes of the folate pathway in the human malaria parasite Plasmodium falciparum.

Authors:  Niroshini Nirmalan; Ping Wang; Paul F G Sims; John E Hyde
Journal:  Mol Microbiol       Date:  2002-10       Impact factor: 3.501

View more
  83 in total

1.  Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites.

Authors:  Puran S Sijwali; Kentaro Kato; Karl B Seydel; Jiri Gut; Julie Lehman; Michael Klemba; Daniel E Goldberg; Louis H Miller; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-27       Impact factor: 11.205

2.  The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.

Authors:  Kailash C Pandey; Stephanie X Wang; Puran S Sijwali; Anthony L Lau; James H McKerrow; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-17       Impact factor: 11.205

3.  Substrate mapping and inhibitor profiling of falcipain-2, falcipain-3 and berghepain-2: implications for peptidase anti-malarial drug discovery.

Authors:  Manoj K Ramjee; Nicholas S Flinn; Tracy P Pemberton; Martin Quibell; Yikang Wang; John P Watts
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

4.  Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease.

Authors:  Stephanie X Wang; Kailash C Pandey; John R Somoza; Puran S Sijwali; Tanja Kortemme; Linda S Brinen; Robert J Fletterick; Philip J Rosenthal; James H McKerrow
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

5.  Inhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d.

Authors:  S Eksi; B Czesny; G-J van Gemert; R W Sauerwein; W Eling; K C Williamson
Journal:  Antimicrob Agents Chemother       Date:  2006-12-18       Impact factor: 5.191

6.  Falcipain-1, a Plasmodium falciparum cysteine protease with vaccine potential.

Authors:  Amit Kumar; Krishan Kumar; Reshma Korde; Sunil Kumar Puri; Pawan Malhotra; Virander Singh Chauhan
Journal:  Infect Immun       Date:  2007-01-22       Impact factor: 3.441

7.  Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatin.

Authors:  Sunil Parikh; Jun Liu; Puran Sijwali; Jiri Gut; Daniel E Goldberg; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

8.  Improved prediction of malaria degradomes by supervised learning with SVM and profile kernel.

Authors:  Rui Kuang; Jianying Gu; Hong Cai; Yufeng Wang
Journal:  Genetica       Date:  2008-12-06       Impact factor: 1.082

9.  Plasmodium yoelii inhibitor of cysteine proteases is exported to exomembrane structures and interacts with yoelipain-2 during asexual blood-stage development.

Authors:  Ying Pei; Jessica L Miller; Scott E Lindner; Ashley M Vaughan; Motomi Torii; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2013-03-14       Impact factor: 3.715

10.  Antimalarial activity of thiosemicarbazones and purine derived nitriles.

Authors:  Jeremy P Mallari; Wendyam A Guiguemde; R Kiplin Guy
Journal:  Bioorg Med Chem Lett       Date:  2009-05-05       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.